Table 2.
Univariate analysis | Multivariable analysis | |||
---|---|---|---|---|
HR (95%CI) | P value | HR (95%CI) | P value | |
Age | ||||
< 75 | 1 [Reference] | 1 [Reference] | ||
≥ 75 | 2.17 (1.67–2.81) | < 0.001† | 1.95 (1.48–2.60) | < 0.001† |
Sex | ||||
Female | 1 [Reference] | 1 [Reference] | ||
Male | 1.24 (0.95–1.61) | 0.105 | 1.45 (1.09–1.93) | 0.009† |
Race | ||||
Other | 1 [Reference] | 1 [Reference] | ||
Black | 1.59 (0.79–3.19) | 0.194 | 1.45 (0.71–2.98) | 0.306 |
White | 0.81 (0.47–1.39) | 0.446 | 0.85 (0.49–1.49) | 0.586 |
Marital status | ||||
Single | 1 [Reference] | 1 [Reference] | ||
Divorced/separated | 0.90 (0.53–1.54) | 0.706 | 1.14 (0.66–1.95) | 0.634 |
Married/partner | 0.51 (0.34–0.77) | 0.002 | 0.61 (0.40–0.94) | 0.023† |
Widowed | 0.74 (0.45–1.21) | 0.244 | 0.74 (0.45–1.21) | 0.244 |
Insurance status | ||||
Insured | 1 [Reference] | 1 [Reference] | ||
Medicaid | 0.44 (0.30–0.64) | < 0.001† | 0.53 (0.36–0.79) | < 0.002† |
Uninsured | / | / | / | / |
Primary site | ||||
Temporal | 1 [Reference] | 1 [Reference] | ||
Brainstem | / | / | / | / |
Cerebellum | 0.62 (0.09–4.42) | 0.630† | 0.43 (0.06–3.15) | 0.409 |
Cerebrum | 1.97 (0.79–4.85) | 0.143 | 1.49 (0.59–3.73) | 0.400 |
Frontal | 0.87 (0.62–1.23) | 0.445 | 0.85 (0.60–1.19) | 0.341 |
Occipital | 1.09 (0.64–1.87) | 0.755 | 1.11 (0.65–1.90) | 0.710 |
Overlapping | 0.93 (0.60–1.42) | 0.722 | 0.90 (0.59–1.39) | 0.641 |
Parietal | 1.14 (0.80–1.63) | 0.477 | 1.05 (0.73–1.51) | 0.792 |
Ventricle | / | / | / | / |
Size | ||||
≤ 5.4 | 1 [Reference] | 1 [Reference] | ||
> 5.4 | 1.07 (0.79–1.46) | 0.652 | 1.18 (0.86–1.61) | 0.300 |
Metastasis | ||||
No | 1 [Reference] | 1 [Reference] | ||
Yes | 3.01 (1.32–6.87) | 0.009 | 2.33 (0.99–5.47) | 0.052 |
Surgery | ||||
Biopsy | 1 [Reference] | 1 [Reference] | ||
GTR | 0.60 (0.45–0.81) | 0.001† | 0.67 (0.49–0.90) | 0.010† |
STR | 0.75 (0.53–1.07) | 0.116 | 0.87 (0.61–1.25) | 0.461 |
Adjuvant therapy | ||||
No/unknown | 1 [Reference] | 1 [Reference] | ||
Both | 0.23 (0.16–0.31) | < 0.001† | 0.27 (0.20–0.37) | < 0.001† |
Chemotherapy | 0.24 (0.09–0.65) | 0.005† | 0.24 (0.09–0.68) | 0.007† |
Radiotherapy | 0.56 (0.37–0.85) | 0.007† | 0.55 (0.36–0.84) | 0.006† |
GTR gross total resection, STR subtotal resection.
†P < 0.05, statistically significant;